Citation

Vulser H, Vulser C, Rieutord M, Passeron A, Lefebvre D, Baup E, Seigneurie AS, Thauvin I, Limosin F, Lemogne C. J. Psychiatr. Pract. 2018; 24(1): 56-59.

Affiliation

H. VULSER, LIMOSIN, and LEMOGNE: Service de Psychiatrie de l'adulte et du sujet âgé, AP-HP, Hôpitaux Universitaires Paris Ouest; Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine; and Inserm, U894, Centre Psychiatrie et Neurosciences, Paris, France C. VULSER, LEFEBVRE: Service d'Anesthésie Réanimation, AP-HP, Hôpitaux Universitaires Paris Ouest, Paris, France RIEUTORD, BAUP, SEIGNEURIE, and THAUVIN: Service de Psychiatrie de l'adulte et du sujet âgé, AP-HP, Hôpitaux Universitaires Paris Ouest PASSERON: Service de Médecine Interne, AP-HP, Hôpitaux Universitaires Paris Ouest, Paris, France.

Copyright

(Copyright © 2018, Lippincott Williams and Wilkins)

DOI

10.1097/PRA.0000000000000282

PMID

29320385

Abstract

Low-dose infusion of ketamine may have rapid antisuicide properties. Such a treatment may therefore be useful in the general hospital to prevent suicide in an environment that cannot be made safe enough. We report on the use of ketamine as an efficient, well-tolerated treatment for persistent suicidal ideation in a patient hospitalized in a general hospital after a severe suicide attempt. Based on data in the literature, we suggest that the benefit-risk ratio for ketamine use in such a context is highly favorable.

Language: en